サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1672134

化学発光免疫測定（Clia）分析装置の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2025年から2033年までの予測

Global Chemiluminescence Immunoassay (Clia) Analyzers Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日
ページ情報
英文 236 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
化学発光免疫測定（Clia）分析装置の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2025年から2033年までの予測
出版日: 2025年03月01日
発行: Value Market Research
ページ情報: 英文 236 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

化学発光免疫測定（Clia）分析装置の世界市場規模は、2024年の194億4,000万米ドルから2033年には381億3,000万米ドルに成長し、2026年から2033年の予測期間中に7.77％の堅調な年間平均成長率（CAGR）を示すと予測されます。

化学発光免疫測定（Clia）分析装置市場は、さまざまな臨床用途における正確で効率的な診断検査に対する需要の高まりに牽引され、大きな成長が見込まれています。Clia分析装置は、ホルモン、感染症、腫瘍マーカーの検出に広く使用されており、患者管理に不可欠な迅速で信頼性の高い結果を提供します。慢性疾患や感染症の流行が増加するにつれて、高度なClia分析装置に対する需要は増加すると予想され、この市場は堅調な拡大が見込まれます。

さらに、Clia技術の進歩が市場の技術革新を後押ししています。感度と特異度を向上させたハイスループット・アナライザーの開発により、検査室の検査効率が向上しています。こうした技術革新は、検査結果の迅速化を促進するだけでなく、検査室がより多くの検体を取り扱うことを可能にし、業務効率を向上させています。調査手法の新たな応用と改良の研究が進むにつれ、診断能力の向上が期待され、市場はさらに拡大すると思われます。

さらに、個別化医療と予防ヘルスケアへの重点の高まりが、Clia分析装置の展望を形成しています。ヘルスケア・プロバイダーが個々の患者のプロファイルに合わせた治療にますます重点を置くようになるにつれ、バイオマーカーや疾病状態に関する詳細な洞察を提供できる分析装置への需要が高まるものと思われます。この動向は、正確な測定が治療方針の決定に大きな影響を与える腫瘍学と内分泌学に特に関連しています。化学発光免疫測定装置市場が進化を続ける中、技術の進歩、個別化医療への注目の高まり、患者の転帰改善へのコミットメントの組み合わせが、将来の軌道を形成する上で重要な役割を果たすと思われます。

当社のレポートは、様々な産業や市場に関する包括的かつ実用的な洞察をお客様に提供するために、細心の注意を払って作成されています。各レポートは、市場情勢を完全に理解するために、いくつかの重要な要素を含んでいます：

市場概要：市場概要：定義、分類、業界の現状など、市場に関する詳細なイントロダクション。

市場促進要因：市場成長に影響を与える主な促進要因・抑制要因・市場促進要因・課題を詳細に分析します。このセクションでは、技術の進歩、規制の変更、新たな動向などの要因を検証します。

セグメンテーション分析：製品タイプ、用途、最終用途、地域などの基準に基づき、市場を明確なセグメントに内訳。この分析により、各セグメントの業績と将来性を明らかにします。

競合情勢：市場シェア、製品ポートフォリオ、戦略的イニシアティブ、財務実績など、主要市場プレイヤーの包括的評価。主要企業が採用する競合力学と主要戦略に関する考察を提供します。

市場予測：過去のデータと現在の市場状況に基づき、一定期間における市場規模と成長動向を予測します。これには、定量的分析と将来の市場軌跡を示すグラフ表示が含まれます。

地域分析：地域ごとの市場パフォーマンスを評価し、主要市場や地域動向を明らかにします。地域の市場力学とビジネスチャンスを理解するのに役立ちます。

新たな動向と機会：現在の市場動向と新たな市場動向、技術革新、潜在的な投資対象分野を特定します。将来の市場開拓と成長見通しに関する洞察を提供します。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 化学発光免疫測定（Clia）分析装置産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 化学発光免疫測定（Clia）分析装置の世界市場分析：タイプ別

  • タイプ別、概要
  • タイプ別、過去および予測データ分析
  • 高スループット
  • 中スループット
  • 低スループット

第6章 化学発光免疫測定（Clia）分析装置の世界市場分析：製品別

  • 製品別、概要
  • 製品別、過去および予測データ分析
  • 試薬
  • 分析装置
  • 消耗品

第7章 化学発光免疫測定（Clia）分析装置の世界市場分析：用途別

  • 用途別、概要
  • 用途別、過去および予測データ分析
  • 腫瘍学・内分泌学
  • 肝炎とレトロウイルス
  • 心臓マーカー
  • 感染症
  • 骨・ミネラル疾患
  • 自己免疫疾患
  • アレルギー
  • 消化器便検査
  • 創薬と開発

第8章 化学発光免疫測定（Clia）分析装置の世界市場分析：最終用途別

  • 最終用途別、概要
  • 最終用途別、過去および予測データ分析
  • 病院・クリニック
  • 医療・診断研究所
  • 製薬会社

第9章 化学発光免疫測定（Clia）分析装置の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋地域売上分析
    • 概要、実績と予測
    • アジア太平洋地域：セグメント別
    • アジア太平洋地域国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋地域
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ

第10章 化学発光免疫測定（Clia）分析装置企業の競合情勢

  • 化学発光免疫測定（Clia）分析装置市場の競合
  • 提携・協力・合意
  • 合併・買収
  • 新製品発表
  • その他の開発

第11章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Abbott
  • Hoffmann-La Roche Ltd
  • Siemens Healthcare GmbH（Siemens AG）
  • Danaher（Beckman Coulter Inc.）
  • DiaSorin S.P.A.
  • Ortho Clinical Diagnostics（Part Of Carlyle Group）
  • Shenzhen New Industries Biomedical Engineering Co.Ltd.
  • Sysmex Corporation
  • Randox Laboratories Ltd.
  • Tosoh Corporation
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Type (Units and USD MN)
  • High Throughput Market Sales By Geography (Units and USD MN)
  • Medium Throughput Market Sales By Geography (Units and USD MN)
  • Low Throughput Market Sales By Geography (Units and USD MN)
  • Analysis By Product (Units and USD MN)
  • Reagents Market Sales By Geography (Units and USD MN)
  • Analyzer Market Sales By Geography (Units and USD MN)
  • Consumables Market Sales By Geography (Units and USD MN)
  • Analysis By Application (Units and USD MN)
  • Oncology & Endocrinology Market Sales By Geography (Units and USD MN)
  • Hepatitis and Retroviruses Market Sales By Geography (Units and USD MN)
  • Cardiac Markers Market Sales By Geography (Units and USD MN)
  • Infectious Disease Market Sales By Geography (Units and USD MN)
  • Bone and Mineral Disorders Market Sales By Geography (Units and USD MN)
  • Auto-Immune Diseases Market Sales By Geography (Units and USD MN)
  • Allergy Market Sales By Geography (Units and USD MN)
  • GI Stool Testing Market Sales By Geography (Units and USD MN)
  • Drug Discovery and Development Market Sales By Geography (Units and USD MN)
  • Analysis By End User (Units and USD MN)
  • Hospitals & Clinics Market Sales By Geography (Units and USD MN)
  • Medical & Diagnostic Laboratories Market Sales By Geography (Units and USD MN)
  • Pharmaceutical Companies Market Sales By Geography (Units and USD MN)
  • Global Chemiluminescence Immunoassay (Clia) Analyzers Market Sales By Geography (Units and USD MN)
  • North America Market Analysis (Units and USD MN)
  • United States Market Analysis (Units and USD MN)
  • Canada Market Analysis (Units and USD MN)
  • Mexico Market Analysis (Units and USD MN)
  • Europe Market Analysis (Units and USD MN)
  • Europe Market Estimate By Country (Units and USD MN)
  • United Kingdom Market Analysis (Units and USD MN)
  • France Market Analysis (Units and USD MN)
  • Germany Market Analysis (Units and USD MN)
  • Italy Market Analysis (Units and USD MN)
  • Russia Market Analysis (Units and USD MN)
  • Spain Market Analysis (Units and USD MN)
  • Rest of Europe Market Analysis (Units and USD MN)
  • Asia Pacific Market Analysis (Units and USD MN)
  • China Market Analysis (Units and USD MN)
  • Japan Market Analysis (Units and USD MN)
  • India Market Analysis (Units and USD MN)
  • South Korea Market Analysis (Units and USD MN)
  • Australia Market Analysis (Units and USD MN)
  • South East Asia Market Analysis (Units and USD MN)
  • Rest of Asia Pacific Market Analysis (Units and USD MN)
  • Latin America Market Analysis (Units and USD MN)
  • Brazil Market Analysis (Units and USD MN)
  • Argentina Market Analysis (Units and USD MN)
  • Peru Market Analysis (Units and USD MN)
  • Chile Market Analysis (Units and USD MN)
  • Rest of Latin America Market Analysis (Units and USD MN)
  • Middle East & Africa Market Analysis (Units and USD MN)
  • Saudi Arabia Market Analysis (Units and USD MN)
  • UAE Market Analysis (Units and USD MN)
  • Israel Market Analysis (Units and USD MN)
  • South Africa Market Analysis (Units and USD MN)
  • Rest of Middle East and Africa Market Analysis (Units and USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Chemiluminescence Immunoassay (Clia) Analyzers Report
  • Market Research Process
  • Market Research Methodology
  • Global Chemiluminescence Immunoassay (Clia) Analyzers Market Size, By Region (Units and USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Type
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End User
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Type (Units and USD MN)
  • High Throughput Market Sales By Geography (Units and USD MN)
  • Medium Throughput Market Sales By Geography (Units and USD MN)
  • Low Throughput Market Sales By Geography (Units and USD MN)
  • Global Market Analysis By Product (Units and USD MN)
  • Reagents Market Sales By Geography (Units and USD MN)
  • Analyzer Market Sales By Geography (Units and USD MN)
  • Consumables Market Sales By Geography (Units and USD MN)
  • Global Market Analysis By Application (Units and USD MN)
  • Oncology & Endocrinology Market Sales By Geography (Units and USD MN)
  • Hepatitis and Retroviruses Market Sales By Geography (Units and USD MN)
  • Cardiac Markers Market Sales By Geography (Units and USD MN)
  • Infectious Disease Market Sales By Geography (Units and USD MN)
  • Bone and Mineral Disorders Market Sales By Geography (Units and USD MN)
  • Auto-Immune Diseases Market Sales By Geography (Units and USD MN)
  • Allergy Market Sales By Geography (Units and USD MN)
  • GI Stool Testing Market Sales By Geography (Units and USD MN)
  • Drug Discovery and Development Market Sales By Geography (Units and USD MN)
  • Global Market Analysis By End User (Units and USD MN)
  • Hospitals & Clinics Market Sales By Geography (Units and USD MN)
  • Medical & Diagnostic Laboratories Market Sales By Geography (Units and USD MN)
  • Pharmaceutical Companies Market Sales By Geography (Units and USD MN)
  • Global Market Sales (Units and USD MN)
  • North America Market Sales (Units and USD MN)
  • Europe Market Sales (Units and USD MN)
  • Asia Pacific Market Sales (Units and USD MN)
  • Latin America Market Sales (Units and USD MN)
  • Middle East & Africa Market Sales (Units and USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
目次
Product Code: VMR11218073

Global Chemiluminescence Immunoassay (Clia) Analyzers Market size is anticipated to grow from USD 19.44 Billion in 2024 to USD 38.13 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 7.77% during the forecast period of 2026 to 2033.

The chemiluminescence immunoassay (CLIA) analyzers market is poised for significant growth, driven by the increasing demand for accurate and efficient diagnostic testing in various clinical applications. CLIA analyzers are widely used for the detection of hormones, infectious diseases, and tumor markers, providing rapid and reliable results that are essential for patient management. As the prevalence of chronic diseases and infectious conditions rises, the demand for advanced CLIA analyzers is expected to increase, positioning this market for robust expansion.

Moreover, advancements in CLIA technology are propelling innovation within the market. The development of high-throughput analyzers with enhanced sensitivity and specificity is improving the efficiency of laboratory testing. These innovations not only facilitate faster turnaround times for test results but also enable laboratories to handle a higher volume of samples, thereby increasing operational efficiency. As research continues to explore new applications and improvements in CLIA methodologies, the market is likely to expand further, driven by the promise of enhanced diagnostic capabilities.

Additionally, the growing emphasis on personalized medicine and preventive healthcare is shaping the CLIA analyzers landscape. As healthcare providers increasingly focus on tailoring treatments to individual patient profiles, the demand for analyzers that can provide detailed insights into biomarkers and disease states is likely to rise. This trend is particularly relevant in the context of oncology and endocrinology, where precise measurements can significantly impact treatment decisions. As the chemiluminescence immunoassay analyzers market continues to evolve, the combination of technological advancements, increased focus on personalized care, and a commitment to improving patient outcomes will play a crucial role in shaping its future trajectory.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Type

  • High Throughput
  • Medium Throughput
  • Low Throughput

By Product

  • Reagents
  • Analyzer
  • Consumables

By Application

  • Oncology & Endocrinology
  • Hepatitis and Retroviruses
  • Cardiac Markers
  • Infectious Disease
  • Bone and Mineral Disorders
  • Auto-Immune Diseases
  • Allergy
  • GI Stool Testing
  • Drug Discovery and Development

By End User

  • Hospitals & Clinics
  • Medical & Diagnostic Laboratories
  • Pharmaceutical Companies
  • COMPANIES PROFILED
  • Abbott
  • Hoffmann-La Roche Ltd
  • Siemens Healthcare GmbH (Siemens AG)
  • Danaher (Beckman Coulter Inc.)
  • DiaSorin S.p.A.
  • Ortho Clinical Diagnostics (Part of Carlyle Group)
  • Shenzhen New Industries Biomedical Engineering Co.Ltd.
  • Sysmex Corporation
  • Randox Laboratories Ltd.
  • Tosoh Corporation
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. CHEMILUMINESCENCE IMMUNOASSAY (CLIA) ANALYZERS INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Product
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By End User
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL CHEMILUMINESCENCE IMMUNOASSAY (CLIA) ANALYZERS MARKET ANALYSIS BY TYPE

  • 5.1. Overview By Type
  • 5.2. Historical and Forecast Data Analysis By Type
  • 5.3. High Throughput Historic and Forecast Sales By Regions
  • 5.4. Medium Throughput Historic and Forecast Sales By Regions
  • 5.5. Low Throughput Historic and Forecast Sales By Regions

6. GLOBAL CHEMILUMINESCENCE IMMUNOASSAY (CLIA) ANALYZERS MARKET ANALYSIS BY PRODUCT

  • 6.1. Overview By Product
  • 6.2. Historical and Forecast Data Analysis By Product
  • 6.3. Reagents Historic and Forecast Sales By Regions
  • 6.4. Analyzer Historic and Forecast Sales By Regions
  • 6.5. Consumables Historic and Forecast Sales By Regions

7. GLOBAL CHEMILUMINESCENCE IMMUNOASSAY (CLIA) ANALYZERS MARKET ANALYSIS BY APPLICATION

  • 7.1. Overview By Application
  • 7.2. Historical and Forecast Data Analysis By Application
  • 7.3. Oncology & Endocrinology Historic and Forecast Sales By Regions
  • 7.4. Hepatitis and Retroviruses Historic and Forecast Sales By Regions
  • 7.5. Cardiac Markers Historic and Forecast Sales By Regions
  • 7.6. Infectious Disease Historic and Forecast Sales By Regions
  • 7.7. Bone and Mineral Disorders Historic and Forecast Sales By Regions
  • 7.8. Auto-Immune Diseases Historic and Forecast Sales By Regions
  • 7.9. Allergy Historic and Forecast Sales By Regions
  • 7.10. GI Stool Testing Historic and Forecast Sales By Regions
  • 7.11. Drug Discovery and Development Historic and Forecast Sales By Regions

8. GLOBAL CHEMILUMINESCENCE IMMUNOASSAY (CLIA) ANALYZERS MARKET ANALYSIS BY END USER

  • 8.1. Overview By End User
  • 8.2. Historical and Forecast Data Analysis By End User
  • 8.3. Hospitals & Clinics Historic and Forecast Sales By Regions
  • 8.4. Medical & Diagnostic Laboratories Historic and Forecast Sales By Regions
  • 8.5. Pharmaceutical Companies Historic and Forecast Sales By Regions

9. GLOBAL CHEMILUMINESCENCE IMMUNOASSAY (CLIA) ANALYZERS MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE CHEMILUMINESCENCE IMMUNOASSAY (CLIA) ANALYZERS COMPANIES

  • 10.1. Chemiluminescence Immunoassay (Clia) Analyzers Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF CHEMILUMINESCENCE IMMUNOASSAY (CLIA) ANALYZERS INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Abbott
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Hoffmann-La Roche Ltd
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Siemens Healthcare GmbH (Siemens AG)
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Danaher (Beckman Coulter Inc.)
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. DiaSorin S.P.A.
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Ortho Clinical Diagnostics (Part Of Carlyle Group)
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Shenzhen New Industries Biomedical Engineering Co.Ltd.
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Sysmex Corporation
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. Randox Laboratories Ltd.
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. Tosoh Corporation
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies